Morristown, N.J., September 27, 2016 – After successfully completing four transformational acquisitions, as well as several other strategic investments, Capsugel today announced that it has unified them all under one brand and unveiled a new corporate campaign that highlights the company’s expanded capabilities for the design, development and manufacture of a wide range of innovative dosage forms.
“I am excited to announce the launch of our new brand campaign centered on the theme of ‘Engineering Medicines to Life,’” said Guido Driesen, President and CEO, Capsugel. “This campaign amplifies Capsugel’s position as a differentiated, specialty CDMO partner with the ingenuity, credibility and flexibility to tackle any product delivery challenge.”
Biopharmaceutical and consumer health and nutrition companies are facing increasingly complex challenges related to their molecules, ingredients and formulations. As a result, they are seeking partners that provide specialized expertise and innovative technologies across the entire spectrum of product development – from early phase design through clinical and commercial manufacturing.
“We heard our customers loud and clear,” added Driesen. “Over the past few years, we have seized several opportunities to complement our proven capsule engineering know-how and establish ourselves as a leading global provider of an even wider range of technology platforms.”
Capsugel’s recent acquisitions and internal investments have greatly expanded its suite of offerings – particularly in the areas of bioavailability enhancement, targeted delivery and other specialized drug delivery technologies – further strengthening its position as a trusted partner for the healthcare industry.
To inspire the brand campaign, the company gathered insights from customers and partners to better understand their needs and the ways they perceive Capsugel as standing apart from other CDMOs. Capsugel’s deep scientific knowledge, product engineering know-how and proven quality track record rose to the top as its most important differentiators in the market and those in highest demand from customers.
“Throughout our history, Capsugel has been at the forefront of innovation in hard capsules and polymer science. So it was no surprise to us that our brand was strong in those areas. What was so gratifying to hear was that because of our science and engineering expertise, our biopharmaceutical and consumer health and nutrition customers ranked us very high in terms of companies they would trust as a CDMO partner,” said Driesen. “With a fundamental understanding of APIs that comes from advancing thousands of drug compounds, predictive models, and expert systems for selecting optimal enabling technologies, Capsugel is bringing premier design capabilities to the CDMO space, which is helping to accelerate customers’ product development cycles and deliver better products to the patients and consumers who need them.”
A print and digital advertising campaign supports the brand rollout and features distinct imagery: the hummingbird, a highly engineered, flexible, fit-for-purpose creature unlike any other – much like the solutions Capsugel provides to its customers. Future campaign graphics will use similar unique imagery to promote the company’s other key differentiation areas.
Capsugel designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health and nutrition industries. Our unique combination of science, engineering, formulation and capsule expertise enables our customers to optimize the bioavailability, targeted delivery and overall performance of their products. We partner with more than 4,000 customers in over 100 countries to create novel, high-quality and customized solutions that align with our customers’ evolving needs and benefit patients and consumers. For more information, visit www.capsugel.com and follow us on Twitter and LinkedIn.